Global Synthetic Oligonucleotides Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Synthetic Oligonucleotides Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development.
Synthetic Oligonucleotides report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Synthetic Oligonucleotides market is projected to reach US$ 14260 million in 2033, increasing from US$ 6782 million in 2022, with the CAGR of 11.2% during the period of 2023 to 2033. Demand from Genetic Testing and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Synthetic Oligonucleotides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Synthetic Oligonucleotides key companies include Merck KGaA, Thermo Fisher Scientific, Creative Biolabs, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies, Inc., GE Healthcare, Kaneka Eurogentec S.A. and GeneDesign, Inc., etc. Merck KGaA, Thermo Fisher Scientific, Creative Biolabs are top 3 players and held % share in total in 2022.
Synthetic Oligonucleotides can be divided into Column-Based Oligos and Array-Based Oligos, etc. Column-Based Oligos is the mainstream product in the market, accounting for % share globally in 2022.
Synthetic Oligonucleotides is widely used in various fields, such as Genetic Testing, Pharmacy and Other,, etc. Genetic Testing provides greatest supports to the Synthetic Oligonucleotides industry development. In 2022, global % share of Synthetic Oligonucleotides went into Genetic Testing filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Synthetic Oligonucleotides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience
Segment by Type
Column-Based Oligos
Array-Based Oligos
Genetic Testing
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Synthetic Oligonucleotides market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Synthetic Oligonucleotides introduction, etc. Synthetic Oligonucleotides Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Synthetic Oligonucleotides market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Synthetic Oligonucleotides report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Synthetic Oligonucleotides market is projected to reach US$ 14260 million in 2033, increasing from US$ 6782 million in 2022, with the CAGR of 11.2% during the period of 2023 to 2033. Demand from Genetic Testing and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Synthetic Oligonucleotides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Synthetic Oligonucleotides key companies include Merck KGaA, Thermo Fisher Scientific, Creative Biolabs, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies, Inc., GE Healthcare, Kaneka Eurogentec S.A. and GeneDesign, Inc., etc. Merck KGaA, Thermo Fisher Scientific, Creative Biolabs are top 3 players and held % share in total in 2022.
Synthetic Oligonucleotides can be divided into Column-Based Oligos and Array-Based Oligos, etc. Column-Based Oligos is the mainstream product in the market, accounting for % share globally in 2022.
Synthetic Oligonucleotides is widely used in various fields, such as Genetic Testing, Pharmacy and Other,, etc. Genetic Testing provides greatest supports to the Synthetic Oligonucleotides industry development. In 2022, global % share of Synthetic Oligonucleotides went into Genetic Testing filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Synthetic Oligonucleotides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience
Segment by Type
Column-Based Oligos
Array-Based Oligos
Segment by Application
Genetic Testing
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Synthetic Oligonucleotides market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Synthetic Oligonucleotides introduction, etc. Synthetic Oligonucleotides Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Synthetic Oligonucleotides market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.